Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

March 15, 2023; Volume 20,Issue 3

Perspectives

  • You have access
    Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
    Jiali Zhang, Bin Liu, Minchao Lyu and Yourong Duan
    Cancer Biology & Medicine March 2023, 20 (3) 169-173; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0745
  • You have access
    Extracellular vesicle-mediated heterogeneous communication between cancer and the lymphatic system facilitates lymphatic metastasis
    Changhao Chen, Yuming Luo, Hanhao Zheng, Dingwen Zhang, Yao Kong, Jiabin Yang, Mingjie An, Yan Lin, Daowei Lin and Rufu Chen
    Cancer Biology & Medicine March 2023, 20 (3) 174-180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0007

Review

  • You have access
    Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
    Tiancheng Zhang, Youpei Lin and Qiang Gao
    Cancer Biology & Medicine March 2023, 20 (3) 181-195; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0002

Original Articles

  • You have access
    Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma
    Tianxing Zhou, Quan Man, Xueyang Li, Yongjie Xie, Xupeng Hou, Hailong Wang, Jingrui Yan, Xueqing Wei, Weiwei Bai, Ziyun Liu, Jing Liu and Jihui Hao
    Cancer Biology & Medicine March 2023, 20 (3) 196-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0569
  • You have access
    A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity
    Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang and Yingying Xu
    Cancer Biology & Medicine March 2023, 20 (3) 218-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0513
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 20 (3)
Cancer Biology & Medicine
Vol. 20, Issue 3
15 Mar 2023
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Perspectives
  • Review
  • Original Articles

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire